— Know what they know.
Not Investment Advice

RTGN OTC

RetinalGenix Technologies Inc.
1W: +0.0% 1M: -0.2% 3M: -0.2% YTD: +24.7% 1Y: +12.7% 3Y: -44.2%
$3.99
+0.00 (+0.00%)
 
OTC · Healthcare · Medical - Devices · Tech Score Sell · Power 43 · $75.2M mcap · 6M float · 0.0001% daily turnover · Short 97% of daily vol

Income Trends

Revenue
$0 +0.0% ▲
Gross Profit
-$954 -854.0% ▼
Operating Income
-$4M -106.8% ▼
Net Income
-$4M -106.7% ▼
EPS (Diluted)
$-0.24 -100.0% ▼
EBITDA
-$4M -106.8% ▼

Profit Margins

Year-over-Year Growth

View Full Income Statement
Line ItemFY2020FY2021FY2022FY2023FY2024
Revenue$0$0$0$0$0
YoY Growth+0.0%+0.0%+0.0%+0.0%+0.0%
Cost of Revenue$0$0$51$100$954
Gross Profit$0$0-$51-$100-$954
Gross Margin—————
R&D Expenses$432K$680K$809K$524K$373K
SG&A Expenses$2M$1M$1M$2M$1M
Operating Expenses$2M$1M$2M$2M$4M
Operating Income-$2M-$2M-$2M-$2M-$4M
Operating Margin—————
Interest Expense$0$3K$5K$4K$4K
Income Before Tax-$2M-$2M-$4M-$2M-$4M
Tax Expense$0$0$0$0$0
Net Income-$2M-$2M-$4M-$2M-$4M
Net Margin—————
EPS (Diluted)$-0.05$-0.15$-0.25$-0.12$-0.24
EBITDA$0$0-$4M-$2M-$4M
Shares Outstanding40M14M16M17M18M

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms